Posts Tagged: "Attorneys"

Michael Bednarek Joins Adams and Reese LLP in Washington, D.C.

The law firm Adams and Reese LLP is enhancing its intellectual property team with the addition of Michael Bednarek to its Washington, D.C. office. Bednarek joins as partner and is a member of the firm’s well-established global Intellectual Property (IP) practice.

Peter McLaughlin Joins Burns & Levinson

Burns & Levinson announced that Peter McLaughlin, a highly respected cybersecurity and data privacy attorney, has joined the firm as a partner in its rapidly expanding Intellectual Property (IP) Group. McLaughlin has nearly 20 years of experience advising U.S. and international clients on their handling of corporate and personal information and complying with cybersecurity, privacy, and data protection standards. He was previously of counsel with DLA Piper in Boston. 

Former Oblon Attorneys Launch Patent Firm Grüneberg and Myers

Dr. Kirsten Grüneberg and Eric Myers are pleased to announce the launch of a new international patent firm, Grüneberg and Myers PLLC. The attorneys both formerly practiced at Oblon, McClelland, Maier & Neustadt LLP, where Grüneberg was head of European Practice. They are forming the firm with a former Oblon colleague, Dr. Richard Chinn, a chemical patent attorney.

Are You at Risk of Being De-Equitized? Is It Time to Look for Option B?

Law firm partners are no longer safe in their positions once they attain equity partnership.   That security is a thing of the past.   If you are a law firm partner, I provide below 7 questions that you can answer that will help you determine if you are about to be de-equitized. This article discusses how to determine whether you are at risk of losing your partnership interest and if so, some steps to strengthen your position.   My next article will give you ways to protect yourself should you be in a situation where your equity partnership share could be taken away.

Matthew L. Fedowitz Joins Buchanan Ingersoll & Rooney

Buchanan Ingersoll & Rooney announces that Matthew L. Fedowitz has joined the firm’s Intellectual Property section as a shareholder in the firm’s Alexandria office. Fedowitz focuses his practice on helping clients in the pharmaceutical, life science and medical device fields with strategic patent portfolio development and patent prosecution, litigation in federal district court and inter partes proceedings before the U.S. Patent Trial and Appeal Board.